View:
Mini BasicThis view is available after user registration.
ShortThis view is available when you buy a license.
StandardThis view is available when you buy a license.
CompleteThis view is available when you buy a license.
Denosumab 60, Breast Cancer, adjuvant
Protocol-ID: 884 V1.0 (Mini), DENO60, Breast Ca, adj.Indication(s)
- Breast Cancer (HR+ postmenopausal); ICD-10 C50.-
Links
- Michael Gnant, Long-term outcomes of adjuvant denosumab in breast cancer: Fracture reduction and survival results from 3,425 patients in the randomised, double-blind, placebo-controlled ABCSG-18 trial. J Clin Oncol 40, 2022 (suppl 16; abstr 507) [DOI]
 | The publishers and authors assume no liability for the accuracy of the contents. The application is at the own responsibility of the treating physician. ©Onkopti. |
Valid since: 04.04.2017